CSOP Hang Seng Biotech ETF (03174.HK) Rose 1.30% to 3.262

Newtimespace News, as of 09:55 on May 19, CSOP Hang Seng Biotech ETF (03174.HK) was quoted at HKD 3.262, up 1.30%. The ETF opened at HKD 3.224, with a high of HKD 3.288 and a low of HKD 3.220. The latest Net Asset Value (NAV) per unit is HKD 3.233, with a premium rate of -0.39%. The asset size is approximately HKD 821 million.

CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotechnology Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to track the overall performance of the 30 largest biotechnology companies listed in Hong Kong that are eligible for Stock Connect trading. The index broadly covers four major business sub-categories: pharmaceuticals, biotechnology, pharmaceutical distribution, and medical equipment and supplies, with a deep focus on core innovation areas in biotechnology such as innovative drugs, CXO (pharmaceutical outsourcing services), and medical devices. This ETF provides investors with a tool for concentrated investment in leading biotechnology companies listed in Hong Kong, offering a high degree of industry concentration.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.